Carvalho-Gomes Â, Pallarés C, Hon-tangas V, et al. Population screening using a point-of-care test reveals unexpectedly low prevalence of active HCV infection in Spain. AASLD 2017, abstract 20.
Europese Commissie keurt risankizumab (Skyrizi) goed voor behandeling matig tot ernstig actieve colitis ulcerosa
okt 2024 | IBD